|
MedChemExpress
acsl4 inhibitor prgl493 ![]() Acsl4 Inhibitor Prgl493, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/acsl4+inhibitor+prgl493/PRGL493/pmc13024497-74-28-32 Average 95 stars, based on 1 article reviews
acsl4 inhibitor prgl493 - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Antioxidants
Article Title: Conjugated Linolenic Acids Induce Ferroptosis in Human and Zebrafish Melanoma Cells
doi: 10.3390/antiox15030360
Figure Lengend Snippet: Effects of ACSL4 or GPX4 inhibitors on the PunA-induced cytotoxicity in melanoma cells. Viability of A375, WM266.4 and ZMEL1 cells treated with punicic acid (PunA) was assessed in the presence of increasing doses of PRGL493 ( a – c ), RSL3 ( d – f ) or ML210 ( g – i ). Relative cell viability was normalized to control cells that were cultured with medium without any added inhibitor or CLnA, defined as 100%. For the cells cultured without CLnA, the culture medium still included the vehicles used for PRGL493, RSL3 and ML210. Data are presented as mean ± standard error of the mean (SEM) of 3 independent experiments. Dose-response curves have been fitted to the data. Statistical significance was assessed by two-way ANOVA with Dunnett’s test, comparing different tested inhibitor concentrations (0.03, 0.1, 0.3, 1, 3, 10 μM) against 0 μM. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****). Only significant differences are shown.
Article Snippet: Additional 96-well plates were subjected to either 2.5 μM PunA (A375 and WM266.4 cells) or 10 μM PunA (ZMEL1 cells), in combination with an increasing dose of the
Techniques: Control, Cell Culture
Journal: Antioxidants
Article Title: Conjugated Linolenic Acids Induce Ferroptosis in Human and Zebrafish Melanoma Cells
doi: 10.3390/antiox15030360
Figure Lengend Snippet: Modulation of acsl4a and gpx4b gene expression in ZMEL1 cells treated with fatty acids. The fold changes in relative quantity (RQ) were calculated for acsl4 a ( a ) or gpx4 b ( b ) in cells exposed to 20 μM of a tested fatty acid for 24 h, relative to the control cells, which were cultured with DMEM without any added fatty acid. The following fatty acids were tested: α-linolenic acid (ALA), oleic acid (OLA), punicic acid (PunA), α-eleostearic acid (α-ESA), β-eleostearic acid (β-ESA) and jacaric acid (JA). The RQ was calculated as RQ = 2 −ΔCt , the ΔC t value representing the difference in C t value between the target gene and a panel of reference genes, which are actin beta 2, beta-2-microglobulin, hypoxanthine phosphoribosyl transferase 1 and TATA-binding protein. Data are presented as mean ± standard error of the mean (SEM) of 3 independent experiments (N = 3, n = 3). Significance was assessed by one-way ANOVA with Tukey’s multiple comparison test among treatments. Significant differences between the fatty acid-treated groups and the control are marked above the columns. p < 0.05 (*); p < 0.01 (**); p < 0.001 (***), p < 0.0001 (****). Only significant differences are shown.
Article Snippet: Additional 96-well plates were subjected to either 2.5 μM PunA (A375 and WM266.4 cells) or 10 μM PunA (ZMEL1 cells), in combination with an increasing dose of the
Techniques: Gene Expression, Control, Cell Culture, Binding Assay, Comparison